mechan
initi
perpetu
multipl
sclerosi
ms
human
demyelin
diseas
central
nervou
system
cn
unknown
clinic
epidemiolog
studi
suggest
genet
environment
factor
import
initi
pathogenesi
ms
viral
infect
associ
demyelin
cn
diseas
human
anim
variou
environment
factor
associ
initi
exacerb
ms
includ
viral
infect
ms
believ
mediat
cell
although
autoreact
cell
isol
blood
normal
healthi
individu
activ
phenotyp
therefor
critic
question
cell
becom
activ
ms
patient
one
potenti
mechan
molecular
mimicri
wherebi
autoreact
cell
may
epitop
infecti
agent
share
structur
sequenc
homolog
self
antigen
direct
evid
molecular
mimicri
human
autoimmun
diseas
difficult
obtain
support
limit
demonstr
vitro
reactiv
cell
clone
ms
patient
panel
antigen
infecti
agent
regard
molecular
mimicri
protein
human
viru
may
associ
ms
candid
autoantigen
epitop
ms
recent
demonstr
therefor
better
understand
potenti
mechan
molecular
autoreact
cell
activ
import
elucid
pathogenesi
ms
previous
demonstr
infect
sjl
mice
strain
theiler
murin
encephalomyel
viru
tmev
encod
myelin
mimic
peptid
haemophilu
influenza
hi
myelin
proteolipid
protein
plp
cell
induc
atyp
cn
autoimmun
diseas
hi
mimic
peptid
share
amino
acid
major
encephalitogen
peptid
sjl
mice
although
sequenc
ident
peptid
structur
ident
amino
acid
primari
mhc
class
ii
tcr
contact
residu
vital
mechan
molecular
mimicri
anoth
potenti
mimic
peptid
identifi
murin
hepat
viru
mhv
rna
coronaviru
mimic
peptid
share
amino
acid
homolog
includ
primari
tcr
mhc
class
ii
contact
residu
neither
secondari
mhc
class
ii
prolin
residu
secondari
tcr
contact
residu
mhv
peptid
bind
induc
limit
activ
cell
clone
deriv
sjl
mice
prolin
residu
posit
mhc
bind
motif
import
bind
demonstr
import
mhc
class
ii
structur
motif
model
molecular
mimicri
may
import
recognit
potenti
mimic
sequenc
addit
demonstr
mhv
mimic
sequenc
natur
immunogen
cell
epitop
sjl
mice
process
mhv
peptid
apc
final
demonstr
autoimmun
diseas
initi
mice
infect
replic
viru
engin
express
natur
mhv
mimic
sequenc
immun
mhv
peptid
cfa
therefor
paper
highlight
structur
requir
myelin
mimic
peptid
critic
import
studi
live
infect
concomit
present
mimic
peptid
previou
investig
identifi
potenti
molecular
mimic
peptid
express
mhv
thu
ask
mimic
peptid
could
cell
follow
immun
mice
plp
peptid
encompass
core
encephalitogen
epitop
cfa
sjl
mice
exhibit
typic
diseas
cours
eae
tabl
contrast
mice
immun
mimic
peptid
mhv
mhv
peptid
contain
minim
epitop
exhibit
clinic
diseas
tabl
abil
mhv
immun
induc
cell
measur
vivo
hypersensit
dth
vitro
cell
prolifer
assay
dth
rechalleng
mice
day
post
immun
cell
howev
dth
respons
significantli
higher
mice
compar
mice
naiv
mice
p
fig
mice
significantli
greater
dth
respons
follow
rechalleng
mhv
compar
control
group
p
interestingli
mice
respond
mhv
rechalleng
suggest
unidirect
molecular
mimicri
fig
also
test
whether
put
sequenc
natur
epitop
sjl
mice
context
mice
immun
peptid
encompass
candid
mimic
epitop
demonstr
dth
respons
vivo
fig
vitro
prolif
respons
fig
upon
rechalleng
mhv
short
peptid
indic
mimic
mhv
epitop
may
process
apc
induc
cell
respons
howev
contrast
vivo
dth
data
vitro
mhv
rechalleng
group
mice
induc
cell
prolifer
fig
result
may
reflect
differ
vitro
vivo
antigen
process
sensit
microenviron
vivo
peptid
rechalleng
contrast
mice
respond
vitro
rechalleng
peptid
albeit
significantli
lower
level
rechalleng
mice
fig
antibodi
stimul
cell
mice
equival
group
fig
c
determin
whether
amino
acid
ident
import
confer
molecular
mimicri
mimic
peptid
produc
alter
mimic
peptid
ligand
substitut
asparagin
n
prolin
p
mhv
peptid
mhvp
fig
immun
mice
either
mhv
mhvp
peptid
cfa
clinic
diseas
induc
either
group
compar
posit
control
mice
immun
tabl
determin
whether
mhvp
immun
induc
prolif
respons
mice
rechalleng
vitro
either
immun
peptid
day
follow
peptid
immun
rechalleng
mice
induc
signific
cell
prolifer
compar
control
group
fig
interestingli
rechalleng
mice
also
induc
modest
cell
prolif
respons
compar
mice
fig
mice
vitro
rechalleng
mhv
induc
greatest
prolif
respons
expect
lesser
respons
mice
fig
respons
mice
similar
naiv
mice
fig
rechalleng
mhvp
induc
strong
respons
mice
fig
addit
mhvp
rechalleng
induc
cell
prolif
respons
mice
fig
contrast
mhv
rechalleng
fig
secret
measur
determin
whether
cell
could
induc
differenti
fig
expect
rechalleng
mice
induc
signific
quantiti
compar
naiv
mice
fig
interestingli
rechalleng
mice
induc
signific
product
fig
contrast
mice
surprisingli
mhv
rechalleng
induc
significantli
greater
respons
fig
mice
compar
mice
popul
cell
respond
mhv
plp
thought
separ
popul
cell
mimic
peptid
fig
b
show
restimul
splenocyt
mhv
induc
greater
prolifer
plp
rechalleng
mice
howev
plp
rechalleng
splenocyt
induc
significantli
larger
secret
mhv
rechalleng
mice
fig
g
therefor
mhvp
peptid
may
target
cell
high
moder
prolifer
rather
cell
high
prolifer
low
secret
differ
popul
may
due
rel
bind
affin
respect
peptid
although
rechalleng
mhvp
peptid
induc
similar
quantiti
mice
rechalleng
mhvp
mhv
induc
respons
mice
fig
antibodi
respons
group
equal
data
shown
substitut
asparagin
prolin
mhv
peptid
increas
potenti
cell
investig
consequ
substitut
prolin
asparagin
peptid
known
mimic
peptid
clinic
diseas
induc
sjl
mice
immun
either
hi
hi
peptid
prolin
substitut
asparagin
tabl
mice
immun
hi
demonstr
signific
prolif
respons
rechalleng
hi
modest
respons
mhvp
mhv
peptid
rechalleng
compar
naiv
mice
fig
contrast
mice
respond
significantli
rechalleng
modestli
hi
peptid
includ
fig
secret
analyz
determin
whether
peptid
less
activ
hi
induc
respons
signific
respons
observ
mice
rechalleng
descend
order
hi
plp
mhvp
compar
control
group
fig
howev
mice
respond
hi
mhv
mhvp
plp
fig
interestingli
mice
also
demonstr
signific
follow
hi
rechalleng
compar
mhv
mice
fig
determin
mimic
potenti
alter
mimic
peptid
ligand
sjl
mice
n
mhvp
day
immun
determin
whether
alter
mhvp
peptid
could
deliv
tolerogen
signal
cell
inhibit
onset
eae
mice
toler
mhvp
exhibit
signific
amelior
clinic
diseas
p
compar
untoler
mice
ova
control
tabl
anticip
toler
nativ
mhv
peptid
inhibit
eae
furthermor
unlik
mice
toler
fail
protect
eae
vivo
dth
vitro
cell
prolif
respons
measur
determin
effect
alter
mimic
peptid
tolerogen
signal
activ
cell
mice
toler
either
mhvp
show
significantli
reduc
dth
prolif
respons
follow
rechalleng
compar
control
group
group
toler
mhv
p
fig
b
group
toler
alter
peptid
mimic
mhvp
demonstr
significantli
lower
higher
dth
prolif
respons
respect
compar
group
toler
nativ
peptid
sequenc
follow
rechalleng
although
p
mhv
peptid
critic
effect
cell
previous
demonstr
weak
stimul
cell
immun
mimic
peptid
cfa
could
enhanc
deliveri
mimic
peptid
encod
infecti
viru
therefor
test
whether
intracerebr
infect
mice
recombin
tmev
engin
express
mhv
peptid
contain
put
mimic
peptid
could
induc
activ
cell
respons
ultim
clinic
diseas
sjl
mice
infect
exhibit
mild
diseas
pronounc
gait
abnorm
similar
sever
earli
onset
mice
infect
tmev
express
self
epitop
fig
contrast
mice
infect
tmev
express
mimic
ova
peptid
vitro
rechalleng
peptid
demonstr
reactiv
cell
present
day
post
infect
mice
measur
secret
fig
contrast
mice
infect
furthermor
signific
respons
peptid
rechalleng
vitro
secret
fig
demonstr
mhv
peptid
like
natur
epitop
sjl
mice
immunohistolog
analysi
brain
day
post
infect
demonstr
modest
number
cell
around
hippocampu
region
mice
fig
contrast
cell
rare
observ
region
mice
fig
mhv
rna
coronaviru
multipl
strain
exist
induc
varieti
diseas
includ
hepat
enter
interestingli
infect
mice
jhm
strain
induc
acut
enceph
chronic
demyelin
cn
similar
ms
patholog
although
coronaviru
infect
human
usual
associ
upper
respiratori
tract
infect
coronaviru
antigen
identifi
demyelin
plaqu
cn
ms
patient
howev
clear
virus
role
ms
patholog
recent
demonstr
infect
mice
recombin
tmev
viru
encod
myelin
mimic
peptid
hi
prime
core
epitop
cfa
could
induc
form
cn
inflammatori
autoimmun
diseas
cell
anoth
potenti
mimic
peptid
homolog
major
encephalitogen
peptid
sjl
mice
although
major
amino
acid
sequenc
differ
natur
plp
viral
mhv
peptid
share
similar
primari
tcr
w
mhc
class
ii
k
contact
residu
locat
gene
code
replic
polyprotein
proteinas
multifunct
protein
involv
transcript
rna
leader
rna
subgenom
mrna
progeni
virion
rna
well
cleav
polyprotein
function
product
locat
n
terminu
replicas
polyprotein
other
demonstr
immun
sjl
mice
induc
expans
cell
although
differenti
minim
mice
exhibit
clinic
sign
cn
autoimmun
diseas
even
multipl
immun
cfa
pertussi
toxin
andor
lp
addit
innat
immun
stimuli
propos
sequenc
mimic
peptid
need
homolog
self
peptid
rather
homolog
key
structur
tcr
mhc
residu
import
mimicri
studi
properti
mhv
mimic
peptid
confirm
carrizosa
et
al
although
immun
sjl
mice
mhv
mimic
epitop
induc
robust
recal
cell
respons
mhv
peptid
observ
minor
recal
respons
particularli
product
nevertheless
data
demonstr
potenti
cell
mhv
peptid
mice
also
observ
trend
toward
follow
recal
mhv
mimic
peptid
confirm
initi
observ
demonstr
despit
limit
mhv
plp
peptid
splenocyt
toler
eae
ineffect
inhibit
diseas
cell
recal
respons
contrast
toler
previous
shown
critic
anchor
residu
ligand
bind
motif
especi
postul
residu
may
critic
suscept
factor
autoimmun
diseas
regard
present
self
peptid
take
observ
attempt
understand
differ
cell
potenti
mimic
peptid
sought
determin
influenc
mhc
class
ii
prolin
anchor
residu
molecular
mimicri
self
epitop
foreign
viral
antigen
secondli
want
establish
whether
viral
deliveri
mhv
mimic
peptid
could
overcom
threshold
necessari
activ
pathogen
autoreact
cell
similar
previous
report
diseas
induct
mimic
peptid
prolin
residu
p
aliphat
mhc
class
ii
ligand
motif
wherea
contain
asparagin
n
amid
interestingli
substitut
secondari
mhc
class
ii
contact
residu
confer
abil
mhv
peptid
induc
stronger
cell
respons
measur
cell
prolifer
elisa
assay
contrast
substitut
hi
mimic
peptid
abrog
abil
peptid
induc
cell
case
mice
made
robust
respons
immun
peptid
expect
gain
loss
prolin
either
induc
negat
mimic
potenti
peptid
respect
interestingli
mice
immun
mhv
respond
strongli
recal
hi
probabl
neither
peptid
contain
p
convers
mhvp
mhv
peptid
recal
challeng
induc
product
cell
mice
like
due
presenc
p
peptid
although
mice
respond
robust
respons
initi
immun
peptid
mice
strong
respons
ie
mice
exhibit
clinic
eae
mimic
cell
shown
compet
produc
suggest
recogn
suffici
reactiv
vivo
cn
endogen
present
plp
peptid
therefor
induc
clinic
eae
although
immun
mhvp
peptid
induc
clinic
diseas
demonstr
increas
plp
compar
mhv
splenocyt
toler
studi
contrast
mhv
splenocyt
protect
mhvp
induc
inhibit
clinic
diseas
toler
cell
similar
toler
induc
hi
plp
effect
mhvp
could
also
measur
suppress
dth
cell
prolif
respons
plp
rechalleng
eae
mice
although
presenc
prolin
secondari
mhc
class
ii
contact
residu
critic
factor
insuffici
induc
eae
upon
prime
sjl
mice
peptid
previous
demonstr
import
studi
peptid
context
concomit
infect
corrobor
hypothesi
infect
mice
tmev
engin
express
mhv
peptid
induc
chronic
autoimmun
diseas
character
atyp
clinic
symptom
similar
sever
time
cours
diseas
initi
tmev
contrast
mice
develop
diseas
like
due
fact
mice
develop
robust
cell
popul
unlik
mice
like
activ
peripher
central
immun
cell
tmev
infect
provid
innat
immun
stimuli
overcom
threshold
activ
cell
mhv
peptid
interestingli
recal
respons
particularli
self
epitop
significantli
higher
mice
respons
mhv
mimic
peptid
like
reflect
prolong
restimul
cell
self
peptid
endogen
releas
consequ
chronic
myelin
damag
present
local
cn
infiltr
dendrit
cell
increas
affin
nm
compar
nm
also
observ
modest
number
cell
brain
mice
day
post
infect
contrast
mice
suggest
presenc
cell
correl
earli
onset
diseas
observ
mice
furthermor
demonstr
mhv
mimic
peptid
natur
epitop
sjl
mous
infect
encod
mhv
mimic
sequenc
could
process
present
apc
measur
vivo
dth
respons
conclus
studi
demonstr
secondari
mhc
class
ii
anchor
residu
play
critic
role
abil
mimic
peptid
induc
molecular
mimicri
lead
induct
cn
autoimmun
diseas
may
import
consider
identifi
candid
mimic
peptid
encod
infecti
pathogen
model
mimic
tmev
allow
us
test
potenti
infecti
peptid
reproduc
immunolog
readout
studi
also
highlight
import
structur
featur
candid
mimic
peptid
may
relev
pathogenesi
ms
also
necess
studi
mimicri
infecti
set
femal
sjl
mice
wk
age
obtain
harlan
indianapoli
mice
hous
barrier
condit
northwestern
univers
medic
school
center
compar
medicin
protocol
approv
northwestern
univers
anim
care
use
committe
paralyz
mice
afford
easier
access
food
water
viru
produc
follow
two
oligonucleotid
woodland
tx
anneal
togeth
form
dna
encod
acid
piec
mhv
ttmlslatakviakwlavnvlyftdvpqik
encompass
core
acid
cell
epitop
cla
restrict
site
end
anneal
oligonucleotid
resuspend
buffer
mm
mm
mm
atp
mm
dithiothreitol
bsa
ph
heat
min
period
min
anneal
dna
digest
cla
insert
tmev
genom
viral
rna
transfect
cell
dmem
medium
produc
infect
viru
stock
mice
infect
intracerebr
inject
pfu
viru
score
weekli
interv
clinic
scale
sign
diseas
mild
gait
abnorm
sever
gait
abnorm
paralysi
one
limb
one
paralyz
limb
moribund
data
plot
mean
clinic
score
group
anim
activ
induc
mice
n
immun
sc
emuls
cfa
contain
mycobacterium
tuberculosi
difco
detroit
mi
distribut
three
site
later
dorsal
hind
flank
peptid
prime
protocol
use
peptid
per
anim
clinic
score
assess
scale
follow
lack
tail
tone
impair
right
reflex
partial
hind
limb
paralysi
total
hind
limb
paralysi
moribund
follow
peptid
purchas
peptid
intern
louisvil
ky
qahslervchclgkwlghpdkfvgityalt
hslgkwlghpdkf
eqlvkwlglpapi
eqlvkwlglnapi
kviakwlavnvl
tmlslatakviakwlavnvlyftdvpqikl
mhvp
kviakwlavpvl
isqavhaahaeineagr
amino
acid
composit
verifi
mass
spectrometri
puriti
assess
hplc
dth
respons
elicit
inject
mice
sc
challeng
peptid
mhv
altern
ear
follow
measur
ear
thick
use
mitutoyo
model
engin
micromet
schlesing
tool
brooklyn
ny
h
follow
peptid
challeng
ear
differ
ear
swell
thick
express
unit
inch
sem
spleen
remov
infect
mice
n
variou
time
follow
infect
cell
prolifer
cytokin
analysi
perform
describ
prolifer
determin
triplic
well
peptid
concentr
express
count
per
minut
cpm
cpm
background
subtract
cytokin
analysi
duplic
set
prolifer
well
use
collect
supernat
h
cytokin
concentr
determin
elisa
endogen
minikit
woburn
system
upstat
va
usa
toler
induc
iv
inject
ethylen
syngen
splenocyt
describ
immunohistochemistri
perform
describ
briefli
two
mice
per
experiment
group
anesthet
perfus
pb
day
post
infect
brain
immedi
frozen
oct
mile
laboratori
elkhart
liquid
nitrogen
thick
longitudin
section
brain
section
nonspecif
stain
block
use
antibodi
bd
pharmingen
avidinbiotin
block
kit
vector
laboratori
tissu
stain
antibodi
mous
bd
pharmingen
san
diego
ca
posit
stain
visual
tyramid
signal
amplif
tsa
direct
kit
nen
boston
accord
manufactur
instruct
section
counterstain
dapi
coverslip
vectashield
mount
medium
vector
laboratori
slide
examin
imag
acquir
via
epifluoresc
use
spot
rt
camera
diagnost
instrument
sterl
height
mi
section
group
analyz
magnif
analysi
clinic
sever
present
mean
group
clinic
score
statist
differ
calcul
rank
test
analysi
cytokin
secret
dth
prolifer
respons
multipl
group
perform
anova
